Cybin's embark program announces graduation of facilitators

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeutics®”, today announced the graduation of highly-skilled facilitators from its embark psychedelic-assisted psychotherapy training program.

CYBN Ratings Summary

CYBN Quant Ranking